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VaccineHuman adenovirus type 3 (HAdV-B3) has an apparently stable genome yet remains a major circulating and
problematic respiratory pathogen. Comparisons of the prototype genome to genomes from three current
ﬁeld strains, including two isolated from epidemics, and a laboratory strain, yielded small-scale nucleotide
variations across 50 years of time and space (U.S. and China). This is in contrast to the recombination events
that have been reported recently for HAdV genomes. Recombinant genomes have been identiﬁed in
emergent HAdV pathogens and is a pathway for the molecular evolution of types. These two contrasting
views of HAdV genome stability have repercussions in the development and use of vaccines for countering
HAdV-B3, as well as in the continued effectiveness of vaccines developed against earlier and current
circulating types of HAdV.
© 2009 Elsevier Inc. All rights reserved.Introduction
Human adenovirus (HAdV) is a double-stranded DNA virus that
was among the ﬁrst respiratory viruses characterized (Hilleman and
Werner, 1954; Rowe et al., 1953). They are implicated in a wide range
of human diseases, including respiratory, ocular, metabolic, renal and
gastrointestinal; and they impact immunocompromised individuals
as well as young, healthy populations (Echavarria, 2008). The natural
variation, over a time period of 50 years and across geographic space
(U.S. and China) of HAdV-B3 at the whole genome level is reported,
comparing the prototype GB strain, which was isolated from a
“common cold volunteer” (USA, 1953), with a ﬁeld strain recovered
from a patient in the U.S. nearly 50 years later, and compares both
with two recent South China epidemic strains (Zhang et al., 2006), as
well as with a laboratory-circulating GB strain from Europe (Sirena et
al., 2005). The ﬁndings indicate a remarkable conservation and
stability of sequences within the genomes across the 50-year time
span and across geographic distances. These data stand in contrast to
the recombination-driven new isolates that are being characterized
recently using genomic and computational analyses (Walsh et al.,
2009; Yang et al., 2009).hadevan), jseto@gmu.edu
@gmu.edu (D. Seto).
, Vanderbilt University, Nash-
ll rights reserved.HAdV-B3, a member of the B1 subspecies, causes acute
respiratory disease (ARD). This pathogen is identiﬁed in epidemics,
is highly virulent and is associated with clinical manifestations of
considerable severity including residual lung damage and fatal
outcomes (Ryan et al., 2002). HAdV-B3 is found in outbreaks in the
U.S., for example, reported in children and military recruits (Ryan et
al., 2002), and is a global concern, for example, reported in Asia (Kim
et al., 2003; Li et al., 1996) and South America (Kajon et al., 1996),
which echo earlier reports of HAdV-B3 isolates across six continents
(Li and Wadell, 1988). Restriction enzyme (RE) pattern analysis
from those studies revealed limited genome changes over time and
location, with overall genome stability, e.g., HAdV-B3a dominating in
Japan from 1962 to 1988, with occasional HAdV-B3a8 and B3c
reported in the same population (Shiao et al., 1996); and HAdV-B3a2
dominating in China from 1962 to 1988, with occasional HAdV-B3a4,
B3a5 and B3a6 (Li and Wadell, 1988; Li et al., 1996). However,
it should be noted that HAdV-B3 is not immune to recombina-
tion events, for example, a putative recombination event involving
HAdV-B3 has been hypothesized as a mechanism resulting in the
emergence of HAdV-B7h, characterized in a South American (south
cone) outbreak. This strain is apparently more devastating than
other HAdV-B7 strains and contains an HAdV-B3-like ﬁber (Kajon
and Wadell, 1996).
In contrast to this apparent stability of these HAdV-B3 genomes,
HAdV in general are known to undergo recombination. Earlier studies
demonstrated in vitro recombination (Boursnell and Mautner, 1981a)
as well as illegitimate recombination involving foreign DNA (Ling,
Table 1
Genome identities of selected adenoviruses versus HAdV-B3 GB. The GC contents of
these adenoviruses are also shown.
Type/species Genome identity (%) GC (%)
HAdV-B3 GB 100a 51.0
HAdV-B3 NHRC 1276 98.2 50.8
HAdV-B3 GZ1 98.2 51.0
HAdV-B3 GZ2 98.2 51.0
HAdV-B7 96.4 51.0
HAdV-B16 94.3 51.3
HAdV-B21 92.8 51.3
HAdV-B50 92.8 51.2
SAdV-21 86.3 51.2
HAdV-B11 82.7 48.9
HAdV-A12 61.8 46.5
HAdV-C5 64.4 55.2
HAdV-D9 67.4 57.1
HAdV-E4 73.9 57.7
SAdV-25 73.7 58.9
HAdV-F40 61.5 51.2
HAdV-F41 61.3 51.0
TSAdV-1 53.3 50.0
a HAdV-B3 GB against itself.
114 P. Mahadevan et al. / Virology 397 (2010) 113–118Manos, and Gluzman, 1982). These are useful properties for
biotechnology (Bernt et al., 2002). The genomes also undergo recom-
bination in vivo (Boursnell and Mautner, 1981b; Crawford-Miksza
and Schnurr, 1996; Lukashev et al., 2008; Mautner and Mackay, 1984;
Williams et al., 1975), leading to discussions of recombination as a
driving force in HAdV type evolution (Crawford-Miksza and Schnurr,
1996). Apparent recombinant HAdV isolates, isolated from outbreaks,
have been reported in the literature as “intermediates”, with virus
characterization based on serum neutralization and/or limited
molecular typing. These have differing properties when examined at
their hexon and ﬁber determinants. For example, strain 14/11
(hexon/ﬁber) was reported as a respiratory pathogen (Hierholzer
and Pumarola, 1976); and more recently, “intermediates” of species D
were reported (Crawford-Miksza and Schnurr, 1996; Engelmann et
al., 2006; Ishiko et al., 2008). One of these (Engelmann et al., 2006) has
been resolved at the genome level, resulting in the recognition of a
new “type”, HAdV-D53, containing several recombination events that
resulted in an emergent HAdV pathogen that causes highly contagious
epidemic keratoconjunctivitis (EKC) (Walsh et al., 2009). Thus, with
the application of DNA sequencing technology and whole genome
computational analyses, there is now additional “primary sequence”
evidence to support the hypothesis that genome recombination drives
the molecular evolution of HAdV types (Crawford-Miksza and
Schnurr, 1996).
Within the context of the in vitro recombination potential of the
HAdV genome and with the recent genome characterizations of
recombination, i.e., “large-scale” genome changes, it is remarkable
that these strains of circulating HAdV-B3 have relatively stable
genomes, extending a minimum of 50 years, with these particular
strains still remaining major public health problems as respiratory
pathogens globally. This unusual genome stability was also noted
in earlier studies showing that the HAdV-E4p (isolated in the
1950s) and HAdV-E4vac (vaccine strain used in the 1970s and
presumably the circulating ﬁeld strain) genomes as well as the
HAdV-B7p and HAdV-B7vac (similar time line) genomes are re-
markably conserved as well, albeit across a minimum of 20 years
(Purkayastha et al., 2005c). Together, these three observations
provide examples into an alternative, yet successful, mode of
molecular stability of HAdV genomes, in contrast to the recom-
bination-driven mechanism. These data serve to reinforce the
suitability of prophylaxis by vaccines, and suggest that the vac-
cines developed against earlier circulating strains are still effec-
tive today, after 20 and 50 years for HAdV-E4, B7 and B3 (Lyons et
al., 2008; Zhang et al., 2009) and point to the potential effective-
ness of HAdV vaccines being redeveloped. Genome stability is also
a desired property in the application of these genomes as gene
delivery vectors.
Results
Genome sequence comparison
The gross genome parameters of all ﬁve HAdV-B3 viruses are
remarkably similar for these strains isolated at different times (1953,
1997, 2004 and 2005) and across two continents (Asia and North
America). The reference and the circulating laboratory (HAdV-B3
GB2) genomes differ by only two nucleotides (35,345 bp and
35,343 bp); the ﬁeld strain genomes, NHRC 1276, GZ1 and GZ2, are
remarkably similar in length (35,265 bp, 35,273 bp, and 35,269 bp).
Shown in Table 1, the reference HAdV-B3 GB strain displays the
greatest nucleotide percent identity to the other HAdV-B3 strains
(∼98%) and other members of the HAdV-B1 species than to members
of other HAdV species (Table 1). The percent identity between HAdV-
B3 GB and HAdV-11 (B2 species) is lower at 82.7%. There is a dramatic
decrease in percent identity between the GB strain and members of
species A, B, C, D, E, and F. These values range between 61% and 74%.Not surprisingly, the tree shrew adenovirus shows a low 53% identity
with HAdV-B3 GB.
High resolution analysis of these genomes at the nucleotide level
reveals remarkable conservation. Fig. 1 presents three views of the
whole genome analysis. PipMaker dot plot analysis yields unbroken
diagonal lines, indicating high degree of identity across the genomes
(Fig. 1A). A small repetitive sequence, within the E3 region, is noted.
This repetitive sequence is interesting as it appears in the HAdV-B7
sequences as well, but not in the C and E species sequences to date
(Lauer et al., 2004; Purkayastha et al., 2005a,b,c), nor HAdV-D53
(Walsh et al., 2009). The potential signiﬁcance is unknown, however,
the E3 region is involved in host immune response evasion (Kajon
et al., 2005).
The numbers of mismatches and gaps in the ﬁeld strains, with
respect to the reference HAdV-B3 GB strain, are also similar, as
shown in Fig. 1B. Fig. 1C shows selected deletions and insertions
present in the ﬁeld strains with respect to the reference strain. A
9-bp deletion between nucleotide positions 8449 and 8550 short-
ens three overlapping proteins by 3 amino acids in the HAdV-B3
NHRC 1276 strain. This corresponds to the dotted box labelled as
“1” in Fig. 1C. The affected proteins are the E2B terminal protein
precursor, the E2B DNA polymerase and a 12.6 kDa hypothetical
protein. An 8 bp insertion occurs in the L1 region of the ﬁeld strains
and does not affect protein coding potential. This corresponds to
the hatched box noted as “2” in Fig. 1C. There is a 4 amino acid
deletion (QAPS) in the 100 kDa hexon assembly associated protein
of the ﬁeld strains due to a 12 bp deletion in the L4 region, which
corresponds to the dotted box labelled as “3” in Fig. 1C. A number of
deletions occur in the E3 region of the ﬁeld strains and these
include deletions of 9, 14, 11, and 23 bp. These are shown in the
dotted box highlighted as “4” in Fig. 1C. As these deletions occur in
a non-coding region of E3, they do not affect the protein coding
potential.Whole genome phylogenetic analysis
Whole genome phylogeny analysis shows these genomes branch-
ing in a subclade within the B1 group (Fig. 2). The ﬁeld strains HAdV-
B3 GZ1 and GZ2 aremore closely related to each other than they are to
HAdV-B3 NHRC 1276. As a validation of this whole genome
phylogenetic approach, HAdV-E4 groups together with the other
HAdV-E species members. The HAdV-B2 species members 11, 14, 34,
and 35 also group together, as well as the species C, D, and Fmembers.
Fig. 1.Whole genome sequence analysis. (A) PipMaker dot blot comparing HAdV-B3p with ﬁeld strain NHRC 1276 (http://pipmaker.bx.psu.edu/cgi-bin/pipmaker?basic). A short
repetitive element is displayed as two short lines on either side of the main diagonal. (B) Mismatches and gaps between the reference HAdV-B3p and the ﬁeld strains are
characterized and displayed. Gaps, deﬁned by PipMaker, are the number of nucleotides inserted or deleted, and mismatches are base substitutions. (C) Selected insertions, based on
sizes noted, (hatched boxes) and deletions (dotted boxes) reﬂect differences in the ﬁeld strains relative to each other and the reference genome: box 1 is a 9 bp deletion in the E2B
region; box 2 notes 8 bp insertions in the L1 region; box 3 shows 12 bp deletions in the L4 region; and box 4 is a collection of closely spaced deletions of 9 bp, 14 bp, 11 bp and 23 bp in
the E3 region.
Fig. 2. Whole genome phylogenetic analysis. A neighbor-joining tree of several HAdV
whole genome sequences reveals that the HAdV-B3 strains cluster with the other
members of the B1 species. The numbers shown represent percentages of 1000
bootstrap replications. The scale bar is in units of nucleotide substitutions per site.
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Analysis of potential recombination using protein identities, with
the GB strain as reference, and software tools, e.g., SimPlot and
Bootscan, reveal no clear events (data not shown). This is in contrast
to the recent reports of recombination of penton, hexon and other
genome sequences characterized using whole genome analysis and
apparently driving the molecular evolution of HAdV types and
emergence of new pathogens (Robinson et al., 2009; Walsh et al.,
2009; Yang et al., 2009).
Restriction enzyme analysis
Whole genome data allow multiple and more accurate in silico
RE analyses. As a bridge to the important observations and data in
the literature, and to synchronize, compare, and make full use of
still-relevant wet-bench data in the literature (Li et al., 1996; Shiao
et al., 1996), several in silico RE digests were performed with these
genomes. All three ﬁeld strains display the HAdV-B3a RE patterns,
with one representative RE pattern shown (Fig. 3), reconﬁrming
the genome type of the HAdV-B3 GZ1 and GZ2 strains as identiﬁed
originally (Zhang et al., 2006). Of the RE analyses performed
(BamHI, BclI, BglII, HpaI, SalI and SmaI), only BglII and SmaI
showed slight differences between HAdV-B3 NHRC 1276 and the
HAdV-B3 GZ1 and GZ2 genomes, which reﬂects the whole genome
data.
Proteome analysis
The HAdV-B3p and the NHRC 1276 genomes were annotated
using methods earlier (Lauer et al., 2004; Purkayastha et al., 2005a,
b,c). In silico proteome analyses allow an understanding of the
implications of the relatively minor changes in the primary
nucleotide sequences. Table 2 shows the differences in proteins
between the HAdV-B3 GB reference strains and the ﬁeld strains. In
Fig. 3. In silico restriction enzyme analysis. To compare the ﬁeld strains with earlier
genome types reported in the literature, a series of RE analyses were performed. A
representative BamHI pattern is shown. All three ﬁeld strains, despite their nucleotide
sequence differences, show a common pattern consistent with HAdV-B3a. Lane 1
contains the molecular size markers; lane 2 is HAdV-B3p; lane 3 is NHRC 1276; lane 4 is
GZ1; and lane 5 is GZ2.
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and conﬁrmed to be absent in the annotation due to truncation.
The 20.6 -kDa protein is found in both GB genomes, but is present
as nonsense mutations in the three ﬁeld strains. A detailed view of
this difference, as an Artemis screenshot, displays the syntenousTable 2
In silico proteome differences.
HAdV-B3 GB HAdV-B3
GB2
HAdV-B3
NHRC 1276
HAdV-B3
GZ1
HAdV-B3
GZ2
20.6 kDa protein ⁎ – – –
19 kDa protein ⁎ – – –
– – 12.6 kDa
hypothetical
protein
– –
E3 9 kDa glycoprotein ⁎ – – –
Presented are the coding sequences that differed from the HAdV-B3p GB strain. HAdV-
B3p GB and HAdV-B3a NHRC 1276 genomes are newly annotated (51 and 49 potential
coding sequences, respectively). Each genome annotation is reanalyzed to ensure
uniformity, that is, if a coding sequence was missing, or present, in one genome
uniquely, the syntenous region of other genomes was reanalyzed to account for its
actual presence or absence. If annotated uniquely for a genome other than the reference
HAdV-B3p GB, then the protein is noted in that column. “⁎” denotes homolog and “–”
denotes conﬁrmed absence. The 20.6 kDa, 19 kDa proteins and 12.6 kDa proteins are in
the E2B region.regions for comparison, Fig. 4. This 20.6 -kDa protein is truncated
by a stop codon in the ﬁeld strains (the SNP was reconﬁrmed by
additional sequencing). In the E2B region, a 19 -kDa protein is
annotated for HAdV-B3 GB and HAdV-B3 GB2, but is not found in
the ﬁeld strains. As the other three proteins in this particular
region have distinct functions in HAdV DNA replication, this may
represent a critical difference; therefore, further wet-bench work is
indicated by this bioinformatics result.
Two stop codons truncate this protein in the ﬁeld strains, shown in
Table 2, explaining why it was not annotated originally. Additionally,
HAdV-B3 NHRC 1276 has a putative 12.6 kDa hypothetical protein in
the E2B region, which is missing in the annotation of the other four
strains. A re-inspection of those genomes shows that this protein is
truncated by two stop codons in the prototype strains and one stop
codon in the GZ1 and GZ2 strains. A E3 9 -kDa glycoprotein, found in
both HAdV-B3 GB and GB2, is not annotated in any of the three ﬁeld
strains due to truncation by multiple stop codons. Again, wet-bench
research is needed to determine the importance of these computa-
tional genomic predictions.
Discussion
While HAdV genomes are apparently prone to changes via
recombination (Robinson et al., 2009; Walsh et al., 2009; Yang et al.,
2009), a currently circulating HAdV-B3 strain, and, to a limited degree,
strains of HAdV-E4 and B7 (Purkayastha et al., 2005c) contain
relatively stable genomes that are remarkably similar at the
nucleotide level across time and space, accumulating relatively
small genome changes through indels and base substitutions. These
do not diminish the HAdV-B3 pathogenic properties apparently, as
the pathogen maintains its presence and virulence in the population
across a minimum of 50 years.
Why do these HAdV-B3 genomes show so little variability over ﬁve
decades? One reason is the proofreading capability of the adenovirus
DNA polymerase, which enhances the replication ﬁdelity of DNA
genome replication (King et al., 1997). Other constraints remain to be
deﬁned and understood, particularly in the context of the recombi-
nation events that are possible and have been shown for other HAdV
genomes.
Despite the high similarity between the ﬁeld strain and the
prototype genomes, there are interesting differences. One is a 20.6 -
kDa protein found in the prototype strain, but is truncated after 18
amino acids in the ﬁeld strains. Another is the E2B 19 kDa protein
found in the prototype strain, but is truncated after 5 amino acids in
the ﬁeld strains. A third protein is an E3 9 kDa protein that is found in
the prototype strain, but is truncated in the ﬁeld strains. These
truncations occur in the same place within the genes and may be
indicative of mutation hotspots. In the NHRC 1276 ﬁeld strain, there is
a 12.6 kDa protein which is truncated after 89 amino acids in the
prototype strains and after 81 amino acids in the GZ1 and GZ2 ﬁeld
strains. The truncation occurs in the same place in the GZ1 and GZ2
strains; however, this is not surprising given how similar the two are
and given that they were isolated from the same outbreak. Further
wet bench analysis needs to be performed on these proteins to
elucidate their functions and importance.
With the increasing applications of the genomics and bioinfor-
matics approach to HAdV genomes, coupled with the presence of
more cost-effective rapid DNA sequencing technologies, detailed
insights into the molecular recombination and/or the overall stability
of genomes and these roles in driving the evolution of HAdV types and
their pathogenicity and pathoepidemiology are forthcoming, with
much greater resolution. This will lead to an understanding of the
emergence of novel HAdV pathogens, allowing preparations to be
made in identifying and performing surveillance for these pathogens,
and to counter them, perhaps controlling epidemic outbreaks with
effective and appropriate vaccines.
Fig. 4. In silico proteome analysis. A genome annotation tool, Artemis, is used to visualize, display and compare the annotation of two genomes. Landmarks such as coding sequences
are displayed. HAdV-B3p differs from HAdV-B3a by the 20.6 kDa protein, noted in the top panel, which is truncated by a SNP, e.g., nonsense mutation (noted in the amino acid and
nucleotide sequences of the bottom panel), in all three ﬁeld strains. Both reference genomes of HAdV-B3p have the full-length protein (noted in the amino acid and nucleotide
sequences in the top panel). The SNP was conﬁrmed by resequencing the region in both genomes.
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Virus growth, in A549 cells, and DNA production were outsourced
to Virapur, LLC (San Diego, CA). Genome sequencing was provided by
Commonwealth Biotechnologies, Inc. (Richmond, VA), using similar
protocols and strategies for a series of HAdV genomes (Lauer et al.,
2004; Purkayastha et al., 2005a,b,c). In brief, Sanger-based chemistry
using DYEnamic ET Terminator Cycle Sequencing (Amersham
Biosciences; Piscataway, NJ) was resolved on an ABI Prism 377
Sequencer (Applied Biosystems; Foster City, CA), providing average
coverage of 5×, minimum 3×, with both strands sequenced.
Unreliable data were re-sequenced for resolution, either moving the
primers and/or repeating the complementary strand. Additional
sequencing QC was provided by genome annotation, resulting in
PCR-based, primer-driven resequencing to clarify any ambiguities.
Bioinformatics are performed as noted earlier, using similar protocols
(Lauer et al., 2004; Purkayastha et al., 2005a,b,c).
HAdV-B3p GB strain was obtained from ATCC (#VR-3; Manassas,
VA) (GenBank AY599834); ﬁeld strain NHRC 1276 (November 1997),
was obtained from Naval Health Research Center (Kevin Russell; San
Diego, CA) (GenBank AY599836). Another GB genome is available
from GenBank, noted as a laboratory strain from T. Adrian (Germany)(GenBank DQ086466) (Sirena et al., 2005); the extent of laboratory
passages was not available as the strain was obtained from another
researcher who is no longer active in the ﬁeld (personal communica-
tions). This strain is referred to in this work as HAdV-B3 “GB2”. Two
ﬁeld strains, GZ1 and GZ-2, isolated from an outbreak in China
(GenBank DQ099432 and DQ105654) are available and documented
in the literature (Zhang et al., 2006).
PipMaker (http://pipmaker.bx.psu.edu/cgi-bin/pipmaker?basic)
was used to compute alignments of whole genome sequences and to
produce dot plots (Schwartz et al., 2000). Local alignments of the
genome sequences using BlastZ (Schwartz et al., 2003) and plots of
the gap-free segments of the alignments as diagonal lines on the dot
plot are generated. Whole genome percent nucleotide identities and
single protein amino acid percent identities were calculated using the
EMBOSS package (Rice et al., 2000). The genome viewer Artemis was
used to view, annotate and compare adenovirus genomes with each
other (Berriman and Rutherford, 2003).
The whole genome alignments were performed using MAVID
(http://baboon.math.berkeley.edu/mavid) (Bray and Pachter, 2004).
A whole genome phylogenetic tree was constructed usingMEGA4 and
a neighbor-joining algorithm (Tamura et al., 2007; Saitou and Nei,
1987) using the whole genome alignment obtained from MAVID.
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tree. TSAdV-1 (tree shrew adenovirus) was used as the “out group”
sequence since it is a non-primate mammal.
Genome recombination analysis was performed using SimPlot
(Lole et al., 1999). The default parameters used for the BootScan
algorithm implemented in Simplot are: window size, 200 bp; Gap-
Strip, on; step size, 20 bp; number of repetitions, 100; tree method,
neighbor; and distancemodel, Kimura 2-parameter. To compare these
particular genomes with other whole genome data in the literature,
the pDRAW32 software (http://www.acaclone.com/) was used for in
silico RE analysis.
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